Credit Suisse’s Signify Health, Inc. SGFY Stock Holding History

Credit Suisse’s Portfolio SGFY Stock Details SGFY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-125,384	Closed	-$3.59M	–	3912
2022 Q4	$3.59M	Sell	125,384 -32,574	-21%	-$940K	﹤0.01%	1517
2022 Q3	$4.6M	Buy	157,958 +107,352	+212%	+$2.47M	0.01%	1302
2022 Q2	$699K	Buy	50,606 +34,645	+217%	+$488K	﹤0.01%	2628
2022 Q1	$289K	Buy	15,961 +1,116	+8%	+$16K	﹤0.01%	3243
2021 Q4	$212K	Sell	14,845 -10,123	-41%	-$157K	﹤0.01%	4253
2021 Q3	$446K	Buy	24,968 +45	+0.2%	+$1.16K	﹤0.01%	3878
2021 Q2	$748K	Buy	+24,923	New	+$685K	﹤0.01%	3584

Other funds holding SGFY

BHCM

Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Credit Suisse's SGFY Position: Q1 2023 in Review

Credit Suisse sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 125,384 shares — an estimated $3.59M sold.

Credit Suisse first reported a position in SGFY in Q2 2021 and held it in 7 quarters. The position peaked at $4.6M in Q3 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

Credit Suisse reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
Credit Suisse sold 125,384 Signify Health, Inc. shares in Q1 2023, an estimated $3.59M.
Credit Suisse first reported a position in Signify Health, Inc. in Q2 2021 and held it in 7 quarters.
Credit Suisse's Signify Health, Inc. position peaked at $4.6M in Q3 2022.
5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.